Company:  NATERA, INC. (NTRA)
Form Type:  S-3ASR
Filing Date:  9/10/2021 
CIK:  0001604821 
Address:  13011 MCCALLEN PASS
BUILDING A SUITE 100
 
City, State, Zip:  AUSTIN, Texas 78753 
Telephone:  650-249-9090 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$113.67  
Change: 
2.28 (2.05%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$10.66B
Trade NTRA now with 

© 2021  
Description of Business
We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change the management of disease worldwide. Our cell-free DNA, or cfDNA, technology combines our novel molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell, with our statistical algorithms which incorporate data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with best-in-class accuracy and coverage. Our technology has been proven clinically and commercially in the women's health space, in which we develop and commercialize non- or minimally- invasive tests to evaluate risk for, and thereby enable early detection of, a wide range of genetic conditions, such as Down syndrome.
Register and access this filing in:     
  FORM S-3ASR
    CALCULATION OF REGISTRATION FEE
    TABLE OF CONTENTS
    FORWARD-LOOKING STATEMENTS
    WHERE YOU CAN FIND MORE INFORMATION
    PROSPECTUS SUMMARY
    THE OFFERING
    RISK FACTORS
    USE OF PROCEEDS
    SELLING STOCKHOLDERS
      BENEFICIAL OWNERS
    PLAN OF DISTRIBUTION
    DIVIDEND POLICY
    LEGAL MATTERS
    EXPERTS
    PART II
      ITEM 14. Other Expenses of Issuance and Distributions.
      ITEM 15. Indemnification of Directors and Officers.
      ITEM 17. Undertakings.
    SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm